Kazakhstan vs Myanmar: Share of people with HIV who receive antiretroviral therapy
Kazakhstan
74.0%
in 2024
Myanmar
75.0%
in 2024
Kazakhstan rank
66th
Myanmar rank
65th
Share of people with HIV who receive antiretroviral therapy over time
- Kazakhstan
- Myanmar
How they compare
Myanmar currently reports 75.0% against 74.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Kazakhstan ranks 66th and Myanmar ranks 65th of 143 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.2% | 2.4% | 0.2% | Myanmar |
| 2010s | 25.7% | 37.7% | 12.0% | Myanmar |
| 2020s | 65.0% | 73.0% | 8.0% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Kazakhstan or Myanmar?
- Myanmar, at 75.0% against 74.0% in Kazakhstan as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Kazakhstan and Myanmar?
- 1.0%, with Myanmar ahead.
- How many years of comparable data are there for Kazakhstan and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Kazakhstan and Myanmar rank globally for share of people with hiv who receive antiretroviral therapy?
- Kazakhstan ranks 66th and Myanmar ranks 65th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.